MetLife Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Sell |
135,513
-3,519
| -3% | -$290K | 0.06% | 332 |
|
|
2025
Q4 | $11.9M | Sell |
139,032
-6,443
| -4% | -$529K | 0.06% | 307 |
|
|
2025
Q3 | $11.3M | Sell |
145,475
-3,806
| -3% | -$297K | 0.05% | 326 |
|
|
2025
Q2 | $11.7M | Sell |
149,281
-8,685
| -5% | -$648K | 0.07% | 271 |
|
|
2025
Q1 | $11.4M | Sell |
157,966
-3,313
| -2% | -$237K | 0.06% | 298 |
|
|
2024
Q4 | $11.9M | Sell |
161,279
-475
| -0.3% | -$33.2K | 0.06% | 219 |
|
|
2024
Q3 | $10.7M | Sell |
161,754
-4,182
| -3% | -$304K | 0.06% | 246 |
|
|
2024
Q2 | $15.3M | Sell |
165,936
-881
| -0.5% | -$78K | 0.09% | 166 |
|
|
2024
Q1 | $15.9M | Sell |
166,817
-5,137
| -3% | -$432K | 0.11% | 150 |
|
|
2023
Q4 | $13.1M | Sell |
171,954
-3,379
| -2% | -$235K | 0.09% | 167 |
|
|
2023
Q3 | $12.1M | Sell |
175,333
-3,537
| -2% | -$284K | 0.09% | 164 |
|
|
2023
Q2 | $16.9M | Sell |
178,870
-5,333
| -3% | -$464K | 0.12% | 132 |
|
|
2023
Q1 | $15.2M | Sell |
184,203
-240
| -0.1% | -$18.9K | 0.11% | 138 |
|
|
2022
Q4 | $13.8M | Sell |
184,443
-4,103
| -2% | -$316K | 0.1% | 151 |
|
|
2022
Q3 | $15.6M | Sell |
188,546
-2,596
| -1% | -$250K | 0.13% | 126 |
|
|
2022
Q2 | $18.2M | Sell |
191,142
-4,689
| -2% | -$485K | 0.14% | 120 |
|
|
2022
Q1 | $23.1M | Buy |
195,831
+59,467
| +44% | +$6.67M | 0.15% | 109 |
|
|
2021
Q4 | $17.7M | Sell |
136,364
-2,399
| -2% | -$280K | 0.15% | 118 |
|
|
2021
Q3 | $15.7M | Sell |
138,763
-3,342
| -2% | -$381K | 0.14% | 121 |
|
|
2021
Q2 | $14.7M | Sell |
142,105
-4,693
| -3% | -$442K | 0.13% | 132 |
|
|
2021
Q1 | $12.3M | Sell |
146,798
-2,537
| -2% | -$214K | 0.11% | 151 |
|
|
2020
Q4 | $13.6M | Sell |
149,335
-6,254
| -4% | -$519K | 0.13% | 137 |
|
|
2020
Q3 | $12.4M | Sell |
155,589
-5,116
| -3% | -$399K | 0.14% | 139 |
|
|
2020
Q2 | $11.1M | Sell |
160,705
-581
| -0.4% | -$41.3K | 0.13% | 151 |
|
|
2020
Q1 | $10.1M | Sell |
161,286
-4,935
| -3% | -$356K | 0.14% | 138 |
|
|
2019
Q4 | $12.9M | Sell |
166,221
-3,567
| -2% | -$279K | 0.13% | 142 |
|
|
2019
Q3 | $12.4M | Sell |
169,788
-2,625
| -2% | -$184K | 0.14% | 143 |
|
|
2019
Q2 | $10.6M | Sell |
172,413
-4,779
| -3% | -$289K | 0.11% | 164 |
|
|
2019
Q1 | $11.3M | Sell |
177,192
-2,166
| -1% | -$124K | 0.12% | 154 |
|
|
2018
Q4 | $9.16M | Sell |
179,358
-3,378
| -2% | -$171K | 0.11% | 169 |
|
|
2018
Q3 | $10.6M | Sell |
182,736
-3,411
| -2% | -$167K | 0.11% | 168 |
|
|
2018
Q2 | $9.03M | Sell |
186,147
-3,465
| -2% | -$162K | 0.11% | 172 |
|
|
2018
Q1 | $8.82M | Sell |
189,612
-6,819
| -3% | -$296K | 0.1% | 178 |
|
|
2017
Q4 | $7.38M | Buy |
+196,431
| New | +$7.21M | 0.08% | 222 |
|
Other funds holding EW
VCM
VPM
MetLife Investment Management's EW Position: Q1 2026 in Review
MetLife Investment Management reduced its Edwards Lifesciences (EW) stake by 2.5% in Q1 2026, selling an estimated $290K and leaving 135,513 shares worth $10.9M. The position accounts for 0.06% of the portfolio, ranked #332.
MetLife Investment Management first reported a position in EW in Q4 2017 and has held it in 34 quarters since. The position peaked at $23.1M in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- MetLife Investment Management held 135,513 shares of Edwards Lifesciences worth $10.9M as of Q1 2026.
- MetLife Investment Management sold 3,519 Edwards Lifesciences shares in Q1 2026, an estimated $290K.
- Edwards Lifesciences made up 0.06% of MetLife Investment Management's portfolio in Q1 2026, its #332 holding.
- MetLife Investment Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Edwards Lifesciences position peaked at $23.1M in Q1 2022.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.